Abstract
Mesenchymal stem cells represent an adult population of nonhematopoietic cells, which can differentiate into a variety of cell types such as osteocytes, chondrocytes, adipocytes, and myocytes. They display immunomodulatory properties that have led to the consideration of their use for the inhibition of immune responses. In this context, mesenchymal stem cells efficiently inhibit maturation, cytokine production, and the T cell stimulatory capacity of dendritic cells. They also can impair proliferation, cytokine secretion, and cytotoxic potential of T lymphocytes. Moreover, mesenchymal stem cells are able to inhibit the differentiation of B cells to plasma cells by inhibiting their capacity to produce antibodies. A variety of animal models confirm the immunomodulatory properties of mesenchymal stem cells. Clinical studies including patients with severe acute graft-versus-host disease have revealed that the administration of mesenchymal stem cells results in significant clinical responses. Therefore, mesenchymal stem cells improve acute graft-versus-host disease and represent a promising candidate for the prevention and treatment of immune-mediated diseases, due to their immunomodulatory capability and their low immunogenicity.
Highlights
The best characterized source for adult stem cells is still adult bone marrow, which contains a heterogeneous population of cells, including hematopoietic stem cells, macrophages, erythrocytes, fibroblasts, adipocytes, and endothelial cells
When focusing on the specificity of the T cells inhibited by mesenchymal stromal cells (MSCs), studies demonstrated that MSCs exhibit different effects on alloantigen- and virus-specific T cell responses[15]
It was demonstrated that MSCs inhibit the immunostimulatory capacity of human Dendritic cells (DC), which are differentiated from blood monocytes after several days in the presence of various cytokines[29]
Summary
The best characterized source for adult stem cells is still adult bone marrow, which contains a heterogeneous population of cells, including hematopoietic stem cells, macrophages, erythrocytes, fibroblasts, adipocytes, and endothelial cells. 3 Hematology and Bone Marrow Transplantation, Hospital Israelita Albert Einstein - HIAE - São Paulo (SP), Brazil. When focusing on the specificity of the T cells inhibited by MSCs, studies demonstrated that MSCs exhibit different effects on alloantigen- and virus-specific T cell responses[15].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
